Question 1

How many shares of MNPR does NewEdge Advisors, LLC own?

Accepted Answer

As of 2026-Q2, NewEdge Advisors, LLC holds 600 shares of MNPR (MONOPAR THERAPEUTICS INC).

Question 2

What is NewEdge Advisors, LLC's MNPR position worth?

Accepted Answer

As of 2026-Q2, NewEdge Advisors, LLC's MNPR position is worth $55,554.

Question 3

When did NewEdge Advisors, LLC first buy MNPR?

Accepted Answer

Based on available 13F filings, NewEdge Advisors, LLC first reported a position in MNPR in 2024-Q3. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price
2026-Q2 Latest	Unchanged	600	0.0%	$55,554	0.0%	$92.59
2026-Q1	Unchanged	600	0.0%	$32,874	0.0%	$51.88
2025-Q4	Unchanged	600	0.0%	$39,180	0.0%	$65.07
2025-Q3	Unchanged	600	0.0%	$49,002	0.0%	$75.90
2025-Q2	Unchanged	600	0.0%	$21,468	0.0%	$33.60
2025-Q1	Unchanged	600	0.0%	$21,846	0.0%	$40.33
2024-Q4	Unchanged	600	0.0%	$13,200	0.0%	$23.85
2024-Q3	Decreased	600	-80.0%	$4,044	0.0%	$6.77